Low-volume hospital (n = 78 patients) | High-volume hospital (n = 189 patients) | |||
---|---|---|---|---|
m | m | P-value | % bias | |
Age | 67.56 | 65.81 | 0.568 | − 13.5 |
Cancer history | 0.15 | 0.17 | 0.830 | 5.7 |
Ascites | 0.69 | 0.67 | 0.920 | − 2.5 |
Neoadjuvant chemotherapy | 0.52 | 0.57 | 0.712 | 9.6 |
Histology: | ||||
- HGSC | 0.65 | 0.59 | 0.642 | −11.7 |
- LGSC | 0.05 | 0.03 | 0.700 | − 8.2 |
- Mucinous | 0.03 | 0.04 | 0.739 | 6.6 |
-Endometrioid | 0.14 | 0.11 | 0.659 | − 10.6 |
- Clear cell | 0.05 | 0.05 | 0.995 | 0.1 |
- Unknown | 0.08 | 0.17 | 0.318 | 27.5 |
FIGO Stage: | ||||
- I | 0.15 | 0.15 | 0.920 | 2.3 |
- II | 0.08 | 0.07 | 0.916 | − 2.9 |
- III | 0.68 | 0.66 | 0.848 | − 4.7 |
- IV | 0.09 | 0.11 | 0.793 | 6.3 |
Tumor Grade: | ||||
- 1 | 0.06 | 0.05 | 0.717 | − 6.5 |
- 2 | 0.14 | 0.14 | 0.980 | − 0.6 |
- 3 | 0.80 | 0.82 | 0.823 | 5.1 |
Mean: | 7.3 | |||
Median: | 6.3 |